Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata

NCT05051761 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

425

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: Jaktinib
DRUG: placebo

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd